Sigma Planning Corp Sells 177 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Sigma Planning Corp reduced its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 14.8% during the 3rd quarter, Holdings Channel reports. The fund owned 1,016 shares of the biotechnology company’s stock after selling 177 shares during the period. Sigma Planning Corp’s holdings in Axon Enterprise were worth $406,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Foundations Investment Advisors LLC bought a new position in shares of Axon Enterprise during the third quarter worth approximately $221,000. Sequoia Financial Advisors LLC increased its position in Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after buying an additional 81 shares during the period. Zurich Insurance Group Ltd FI lifted its holdings in shares of Axon Enterprise by 1.9% during the second quarter. Zurich Insurance Group Ltd FI now owns 205,015 shares of the biotechnology company’s stock worth $60,324,000 after buying an additional 3,832 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Axon Enterprise by 21.7% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock valued at $2,693,000 after acquiring an additional 1,634 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Axon Enterprise by 23.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,329 shares of the biotechnology company’s stock valued at $2,502,000 after acquiring an additional 1,196 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.9 %

Shares of NASDAQ AXON opened at $599.35 on Friday. The company has a market cap of $45.70 billion, a price-to-earnings ratio of 154.87, a PEG ratio of 15.10 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $220.78 and a 12 month high of $624.84. The stock has a 50-day moving average price of $438.79 and a two-hundred day moving average price of $357.27.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. The trade was a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the transaction, the director now directly owns 7,379 shares of the company’s stock, valued at approximately $2,752,588.37. The trade was a 5.75 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 411,006 shares of company stock valued at $161,360,618. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on AXON. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird raised their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.